enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of investigational sleep drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.

3. Lemborexant - Wikipedia

   en.wikipedia.org/wiki/Lemborexant

   Lemborexant is used in the treatment of insomnia in adults. [3]A major systematic review and network meta-analysis of medications for the treatment of insomnia published in 2022 found that lemborexant had an effect size (standardized mean difference (SMD)) against placebo for treatment of insomnia at 4 weeks of 0.36 (95% CI Tooltip confidence interval 0.08 to 0.63) and at 3 months of 0.41 (95% ...

4. Hypnotic - Wikipedia

   en.wikipedia.org/wiki/Hypnotic

   Zolpidem tartrate, a common but potent sedative–hypnotic drug.Used for severe insomnia. Hypnotic (from Greek Hypnos, sleep [1]), or soporific drugs, commonly known as sleeping pills, are a class of (and umbrella term for) psychoactive drugs whose primary function is to induce sleep [2] (or surgical anesthesia [note 1]) and to treat insomnia (sleeplessness).

5. Sleep Easy, My Friend - AOL

   www.aol.com/news/2012-06-13-sleep-easy-my-friend...

   There's no doubt that Merck's (NYS: MRK) new insomnia drug is innovative. Whether that'll be enough to make it a game-changer remains to be seen. Unlike current sleep medications that work by ...

6. Sleeping pill could reduce levels of Alzheimer’s proteins - AOL

   www.aol.com/news/sleeping-pill-could-reduce...

   The sleeping pill, known as suvorexant, which has been approved by the Food and Drug Administration (FDA) is used to aid insomnia - now researchers are seeing if it can help slow down Alzheimer ...

7. Why the FDA Rejected This New Insomnia Drug - AOL

   www.aol.com/news/2013-07-01-why-the-fda-rejected...

   Shares of Merck closed flat as the market digests the FDA rejection of new insomnia drug suvorexant. However, this rejection is not out of the blue despite a positive FDA advisory committee vote ...